This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Dow ETF in Focus Going Into Q4 Earnings Announcements
by Sweta Killa
The optimism over the earnings season, which will kick start this week, will rekindle investors' confidence in the Dow Jones stocks and ETFs.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $465, marking a +1.4% move from the previous day.
The Zacks Analyst Blog Highlights: Microsoft Corp., UnitedHealth Group Inc., and The Charles Schwab Corp.
by Zacks Equity Research
Microsoft Corp., UnitedHealth Group Inc., and The Charles Schwab Corp. are included in this analyst blog.
Top Stock Reports for Microsoft, UnitedHealth & Schwab
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), UnitedHealth Group Incorporated (UNH), and The Charles Schwab Corporation (SCHW).
Humana (HUM) Cuts Medicare Enrollment Outlook, Tumbles 19.4%
by Zacks Equity Research
Humana (HUM) expects Group Medicare Advantage membership to remain flat in 2022, with competitive pricing possibly playing a crucial role.
Nevro's (NVRO) 10 kHz Therapy for Treatment of PDN Gets Coverage
by Zacks Equity Research
Nevro (NVRO) receives coverage for its high-frequency 10 kHz therapy for the treatment of PDN.
Humana (HUM) Enhances Value-Based Care With Vancouver Clinic
by Zacks Equity Research
Humana (HUM) collaborates with Vancouver Clinic to boost its Medicare Advantage portfolio.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $502.28, moving +0.03% from the previous trading session.
Centene (CNC) Receives DMHC Approval for Magellan Acquisition
by Zacks Equity Research
Centene's (CNC) acquisition with Magellan Health is likely to close on Jan 4, 2022, around a year after the deal announcement.
Here's Why You Should Retain UnitedHealth Group (UNH) Now
by Zacks Equity Research
UnitedHealth Group (UNH) is well-poised for growth on the back of solid top-line growth, expansion of service offerings through UnitedHealthcare and Optum units, and adequate cash flows.
Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DIA
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
by Zacks Equity Research
Sector ETF report for IYH
Zacks Investment Ideas feature highlights: Anthem, UnitedHealth Group and Molina Healthcare
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Anthem, UnitedHealth Group and Molina Healthcare
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $502.94, marking a +0.69% move from the previous day.
Neutralize Higher Health Insurance Premiums In 2022
by Bryan Hayes
Buy These Health Providers to Counteract Bigger Health Insurance Premiums
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
by Zacks Equity Research
Sector ETF report for XLV
The Zacks Analyst Blog Highlights: Microsoft, Home Depot, Goldman Sachs, UnitedHealth Group and Chevron
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, Home Depot, Goldman Sachs, UnitedHealth Group and Chevron .
Should You Invest in the Vanguard Health Care ETF (VHT)?
by Zacks Equity Research
Sector ETF report for VHT
5 Dow Stocks That Helped the Index Score Big in 2021
by Nalak Das
We have narrowed our search to five Dow stocks that have pulled in the most in 2021. These are: MSFT, HD, GS, UNH and CVX.
Cigna (CI), SRHS Tie Up to Offer Enhanced Care in Upstate SC
by Zacks Equity Research
Cigna (CI) inks a deal to expand ties with SRHS. The move equips both healthcare providers to jointly offer enhanced healthcare services across the Upstate community.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $487.21, moving +0.72% from the previous trading session.
4 Health Insurers Poised to Maintain Winning Streak in 2022
by Kaibalya Pravo Dey
Buoyed by government support and technological improvements, stocks in the health insurance industry are likely to witness increased product demand. UNH, ANTM, CNC & MOH are well positioned to make the most of the market improvement.
UnitedHealth Group (UNH) Stock Moves -0.7%: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $483.73, marking a -0.7% move from the previous day.
Teladoc (TDOC) Ties Up to Offer Virtual Care for NLA Members
by Zacks Equity Research
Teladoc Health (TDOC) teams up with NLA in a bid to offer its comprehensive suite of virtual care services to benefit the latter's members.